RxDoctor Payments Data

Jessica Leichty, NP

Psychiatric/Mental Health · Ionia, MINPI 1316568355

Payments from drug & device makers

$2,607in general payments, 2019–2025

Across 172 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$585
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$412
  • Neurocrine Biosciences, Inc.$323
  • Teva Pharmaceuticals USA, Inc.$204
  • Supernus Pharmaceuticals, Inc.$203
  • Vanda Pharmaceuticals Inc.$175
  • plus $706 from 10 others

What the payments were for

  • Food & beverage$2,600100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,607 in reported general payments places this provider in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$5,194
Medicare patients
27
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole24$42,617
LybalviOlanzapine/Samidorphan Malate14$23,075
Lurasidone Hcl16$7,952
Bupropion XlBupropion Hcl18$696
Clozapine35$542
Desvenlafaxine Succinate ErDesvenlafaxine Succinate16$481
Quetiapine Fumarate37$411
Olanzapine22$395
Haloperidol17$389
Buspirone Hcl44$373
Trazodone Hcl42$237
Hydroxyzine Hcl23$224
Risperidone36$202
Mirtazapine23$186
Bupropion Hcl SrBupropion Hcl14$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$90$42,61724 claims
Alkermes, Inc.Lybalvi$106$23,07514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Ionia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →